APT Medical Inc (688617) — Capital Reinvestment Ratio
APT Medical Inc (688617) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.68 Million) in capital expenditures (CN¥52.10 Million). Check 688617 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
APT Medical Inc Capital Reinvestment Ratio (2017–2025)
This chart tracks APT Medical Inc's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 688617 operating cash flow.
Annual Capital Reinvestment Ratio for APT Medical Inc (2017–2025)
Year-by-year Capital Reinvestment Ratio for APT Medical Inc from 2017 to 2025. See cash generation quality of APT Medical Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥975.30 Million | CN¥285.59 Million | ▼ -66.5% |
| 2024 | 0.87x | CN¥743.39 Million | CN¥650.24 Million | ▲ +198.3% |
| 2023 | 0.29x | CN¥689.06 Million | CN¥202.03 Million | ▼ -24.8% |
| 2022 | 0.39x | CN¥367.46 Million | CN¥143.21 Million | ▼ -57.8% |
| 2021 | 0.92x | CN¥181.39 Million | CN¥167.38 Million | ▲ +209.5% |
| 2020 | 0.30x | CN¥148.24 Million | CN¥44.20 Million | ▼ -75.8% |
| 2019 | 1.23x | CN¥54.90 Million | CN¥67.56 Million | ▼ -28.8% |
| 2018 | 1.73x | CN¥18.63 Million | CN¥32.20 Million | ▼ -11.7% |
| 2017 | 1.96x | CN¥12.91 Million | CN¥25.26 Million | — |